Log in

Strides Pharma Science

NSE: STAR · ISIN INE939A01011 · Healthcare

₹1,006.30−29.60 (−2.86%)

Monday 9 November, 13:16 IST. Delayed. Source: Yahoo Finance.

Price chart

₹1,006.30 −29.60 (−2.86%) today

The day

Previous close
₹1,035.90
Open
₹1,025.00
Day high
₹1,039.90
Day low
₹1,005.00

Listed on NSE since 2 February 2000.

Key numbers

Market value
₹9,291.93 Cr
P/E (trailing)
15.61
EPS (trailing)
₹64.57
Price to book
2.72
Dividend yield
0.48%
Return on equity
20.3%
Debt to equity
0.55
Profit margin
11.8%
Beta
0.36
Volume today
1.19 L
Average volume
4.17 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹3,607.67 Cr₹-202.64 Cr₹-22.49
FY24₹3,730.02 Cr₹-70.61 Cr₹-7.76
FY25₹4,391.68 Cr₹3,593.46 Cr₹390.50
FY26₹4,627.97 Cr₹556.19 Cr₹60.34

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q2 FY27Jul–Sep 2026₹1,430 Cr₹131 Cr₹14.19+2.6%
Q1 FY27Apr–Jun 2026₹1,265 Cr₹157 Cr₹17.02+57.5%
Q4 FY26Jan–Mar 2026Audited₹1,323 Cr₹127 Cr₹13.77+54.4%
Q3 FY26Oct–Dec 2025₹1,195 Cr₹202 Cr₹21.92–
Q2 FY26Jul–Sep 2025₹1,221 Cr₹128 Cr₹13.84–
Q1 FY26Apr–Jun 2025₹1,120 Cr₹100 Cr₹10.81–

Source: Strides Pharma Science’s results filed with NSE, consolidated (the whole group). Net profit is the share of Strides Pharma Science’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onSeptember 2026March 2026September 2025
Fixed assets₹1,185 Cr₹1,154 Cr₹1,046 Cr
Investments₹288 Cr₹279 Cr₹430 Cr
Inventories₹1,873 Cr₹1,635 Cr₹1,459 Cr
Owed by customers₹1,464 Cr₹1,289 Cr₹1,130 Cr
Cash and equivalents₹137 Cr₹189 Cr₹123 Cr
Total assets₹7,489 Cr₹6,927 Cr₹6,521 Cr
Borrowings₹1,847 Cr₹1,669 Cr₹1,749 Cr
Total liabilities₹4,018 Cr₹3,778 Cr₹3,718 Cr
Shareholders’ equity₹3,416 Cr₹3,108 Cr₹2,756 Cr

Source: Strides Pharma Science’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

About Strides Pharma Science

Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally. The company offers generic finished dosage formulations in a range of dosages, such as tablets, hard capsules, sachets, liquids, nasal sprays, topical formulations, and controlled substances; and therapeutic products, including antivirals, antibiotics, NSAIDs, and allergy treatment. It also provides branded generics, prescription medicines, and over-the-counter products for infectious diseases, pain management, cardiology, and wellness; and prescription generics for anti-infectives, CNS, cardiovascular, gastroenterology, pain management, and specialty products. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

Industry
Drug Manufacturers - Specialty & Generic
Based in
Bengaluru
Employees
3,535

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name Strides Pharma Science in the last day or two.

Dividends and corporate actions

All companies
  • Dividend - Rs 5 Per Share

    Dividend · ex-date 31 July 2026

  • Dividend - Rs 4 Per Share

    Dividend · ex-date 22 July 2025

  • Demerger

    Action · ex-date 6 December 2024

  • Dividend - Rs 2.50 Per Share

    Dividend · ex-date 9 September 2024

  • Dividend - Rs 1.50 Per Share

    Dividend · ex-date 4 August 2023

  • Dividend - Rs 2.50 Per Share

    Dividend · ex-date 5 August 2021 · record date 6 August 2021

  • Annual General Meeting/Dividend - Rs 2 Per Share

    Dividend · ex-date 24 July 2020 · record date 27 July 2020

  • Interim Dividend - Rs 12 Per Share

    Dividend · ex-date 22 August 2019 · record date 23 August 2019

Source: NSE. Latest first, 8 of 20.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗Angel One ↗For convenience only: no referral, not a recommendation.